Clinical Trial Update: Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer [Phase 3]

View source ↗

Summary

This update describes a Phase 3 trial evaluating a shorter chemo-immunotherapy regimen that omits anthracyclines for early-stage triple-negative breast cancer. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 3 | Status: RECRUITING